Aeromonas hydrophila (A. hydrophila) is responsible for causing abdominal dropsy, swimming abnormalities, skin ulcerations, and pale gills in fish. Vaccination is an essential strategy for disease prevention in aquaculture. This study evaluated the efficacy of an oral vaccine against A. hydrophila in Ctenopharyngodon idella (C. idella). The vaccine was formulated as feed-based monovalent pellets, incorporating or spraying formalin-killed A. hydrophila on/into commercial feed with 30% crude protein. Mineral and fish oils were used as adjuvants at 10% of the feed. Prior to the trial, the experimental feed groups were subjected to quality and safety tests. Grass carp fingerlings (20 ± 5 g) were divided into seven groups (n = 20 per group): sprayed vaccinated feed with fish oil (SVFF), incorporated vaccinated feed with fish oil (IVFF), sprayed vaccinated feed with mineral oil (SVFM), incorporated vaccinated feed with mineral oil (IVFM), sprayed vaccinated feed (SVF), incorporated vaccinated feed (IVF), and a control group. Feed was provided at 3% of body weight for 60 days. Immunomodulation was investigated through lysozyme activity, antibody titers, and immunoglobulin M (IgM). The IVFF group showed significantly enhanced immunity and growth performance, with an 87% protection rate, 13% mortality, and the highest relative percentage survival (83%) following intraperitoneal A. hydrophila (6.8 × 109 CFU/mL) challenge. Histological analysis indicated minimal pathological changes in the IVFF group compared to controls. Fish oil as an adjuvant enhanced immunity without adverse health effects. Overall, this study demonstrated that feed-based monovalent vaccines effectively improve immune responses and provide protection against A. hydrophila in C. idella.
The bacterial pathogens Aeromonas species, notably Aeromonas veronii and Aeromonas hydrophila , are major causative agents of severe infections and significant mortalities in freshwater aquaculture systems. Vaccination offers an effective prophylactic approach to enhance fish immune defenses and reduce reliance on antibiotics. This study aimed to evaluate the immunoprotective efficacy of a bivalent bacterial oral vaccine against these pathogens in carps. The vaccine was formulated by either incorporating or spraying it/onto commercial feed (30% crude protein), with 10% fish oil and mineral oil added as adjuvants. Seven experimental dietary diets were designed, comprising vaccinated feeds administered with or without adjuvants (1 mL of vaccine per gram of feed) and a nonvaccinated control. Healthy fingerlings (20 ± 5 g) were fed their respective diets over a 60‐day experimental period, followed by challenge with Aeromonas spp. To evaluate the effectiveness of the vaccination, immune parameters (serum lysozyme activity, agglutination antibody titers, and IgM levels), growth performance (net weight gain [NWG], specific growth rate [SGR], and feed conversion ratio [FCR]) and survival rates were examined. In comparison to the control, the results indicated that all vaccination diets showed considerably improved immune responses and growth. However, vaccinated diet with fish oil (IVFF) showed the highest immunological stimulation and rate of survival, 83% for Ctenopharyngodon idella ( C. idella ) and 85% for Labeo rohita ( L. rohita ). These results validate the IVFF oral vaccine formulation has potential as a noninvasive, scalable method of providing protective immunization against Aeromonas infections in freshwater aquaculture.